These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 24791767

  • 1. Assessment and management of male androgen disorders: an update.
    Chan I, Fui MN, Zajac JD, Grossmann M.
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [Abstract] [Full Text] [Related]

  • 2. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T.
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [Abstract] [Full Text] [Related]

  • 3. Late-onset hypogonadism and lifestyle-related metabolic disorders.
    Braga PC, Pereira SC, Ribeiro JC, Sousa M, Monteiro MP, Oliveira PF, Alves MG.
    Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
    [Abstract] [Full Text] [Related]

  • 4. Testosterone administration in older men.
    Matsumoto AM.
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [Abstract] [Full Text] [Related]

  • 5. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B, Saad F, Hoesl CE.
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [Abstract] [Full Text] [Related]

  • 6. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI, Huhtaniemi I.
    Gerontology; 2011 Jun; 57(3):193-202. PubMed ID: 20689266
    [Abstract] [Full Text] [Related]

  • 7. Late-life onset hypogonadism: a review.
    Bassil N, Morley JE.
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [Abstract] [Full Text] [Related]

  • 8. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men - a suggested update.
    Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y.
    Aging Male; 2013 Dec; 16(4):143-50. PubMed ID: 24188520
    [Abstract] [Full Text] [Related]

  • 9. Testosterone replacement in men.
    Beg S, Al-Khoury L, Cunningham GR.
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [Abstract] [Full Text] [Related]

  • 10. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL.
    Semin Dial; 2004 Aug; 17(3):202-8. PubMed ID: 15144546
    [Abstract] [Full Text] [Related]

  • 11. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
    Meza J, Weaver K, Martin S.
    Am Fam Physician; 2013 Oct 15; 88(8):Online. PubMed ID: 24364582
    [No Abstract] [Full Text] [Related]

  • 12. Hormonal therapy of male hypogonadism.
    Matsumoto AM.
    Endocrinol Metab Clin North Am; 1994 Dec 15; 23(4):857-75. PubMed ID: 7705324
    [Abstract] [Full Text] [Related]

  • 13. Testosterone replacement in elderly men.
    Baum NH, Crespi CA.
    Geriatrics; 2007 Sep 15; 62(9):15-8. PubMed ID: 17824721
    [Abstract] [Full Text] [Related]

  • 14. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr 18; 53(1362):29-30. PubMed ID: 21502933
    [Abstract] [Full Text] [Related]

  • 15. Clinical hypogonadism and androgen replacement therapy: an overview.
    Ohl DA, Quallich SA.
    Urol Nurs; 2006 Aug 18; 26(4):253-9, 269; quiz 260. PubMed ID: 16939042
    [Abstract] [Full Text] [Related]

  • 16. Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function.
    Golan R, Scovell JM, Ramasamy R.
    Aging Male; 2015 Aug 18; 18(3):201-4. PubMed ID: 26075536
    [Abstract] [Full Text] [Related]

  • 17. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.
    Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, Pacenza N, Stewart Usher J, Bergadá I, Campo SM.
    Andrology; 2013 Jan 18; 1(1):3-16. PubMed ID: 23258624
    [Abstract] [Full Text] [Related]

  • 18. Late-onset hypogonadism: metabolic impact.
    Grossmann M, Ng Tang Fui M, Cheung AS.
    Andrology; 2020 Nov 18; 8(6):1519-1529. PubMed ID: 31502758
    [Abstract] [Full Text] [Related]

  • 19. [Testosterone replacement treatment in older people with and without co-morbidities].
    Zitzmann M.
    Internist (Berl); 2020 Jun 18; 61(6):549-557. PubMed ID: 32377774
    [Abstract] [Full Text] [Related]

  • 20. [Bone and Men's Health. Late-onset hypogonadism in males and male menopause (andropause)].
    Komiya A, Watanabe A, Fuse H.
    Clin Calcium; 2010 Feb 18; 20(2):234-44. PubMed ID: 20118516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.